Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02155946 · ClinicalTrials.gov registry record · NA
Promoting Adaptive Neuroplasticity in Mild Cognitive Impairment
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 107
- Enrollment target
NCT02155946: Completed NA study, sponsored by VA Office of Research and Development.
NCT02155946 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 107 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02155946, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 107 participants
- Enrollment target
Study Summary
The aging US population threatens to overwhelm our healthcare infrastructure, especially since the rate of Alzheimer's disease (AD) alone is expected to triple in the coming decades. Memory cause functional impairment, reduced quality of life, increased caregiver burnout, and eventual institutionalization. The diagnosis of mild cognitive impairment (MCI) identifies those with memory deficits but who remain relatively independent in everyday life. MCI provides a window for interventions that target memory functioning. The proposed study focuses specifically on a groundbreaking combination of mnemonic rehabilitation and non-invasive brain stimulation. The main idea is that brain stimulation can enhance functioning in the specific brain regions/networks, thereby increasing the patients' ability to benefit from different types of memory rehabilitation. This will be a randomized, double-blind study (active vs. fake brain stimulation), that provides multiple treatment session. Outcome will be examined using both laboratory-based and real-world memory testing as well as brain imaging. This first-of-its-kind study has the potential to meaningfully translate more "basic" science findings into neuroanatomically targeted and functionally meaningful treatments for our aging population.
Interventions
- DEVICE Transcranial direct current stimulation (tDCS) Soterix Medical Inc. tDCS unit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2014-12-01 |
| Est. Completion | 2021-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02155946
The ClinicalTrials.gov registry entry for NCT02155946 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 107 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transcranial direct current stimulation (tDCS) Soterix Medical Inc. tDCS unit is the first listed.
NCT02155946 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02155946 about?
NCT02155946 is a clinical study titled "Promoting Adaptive Neuroplasticity in Mild Cognitive Impairment". The aging US population threatens to overwhelm our healthcare infrastructure, especially since the rate of Alzheimer's disease (AD) alone is expected to triple in the coming decades. Memory cause functional impairment, reduced quality of life, increased caregiver burnout, and eventual institutionali...
What is the current status of trial NCT02155946?
This trial is currently completed. It is a NA study. The enrollment target is 107 participants. The study started on 2014-12-01. Estimated completion is 2021-03-31.
What interventions are being tested in trial NCT02155946?
The interventions under investigation include: Transcranial direct current stimulation (tDCS) Soterix Medical Inc. tDCS unit (DEVICE).
Who is sponsoring clinical trial NCT02155946?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.